Differences between neurofibromatosis-1-associated malignant peripheral nerve sheath tumors (MPNST) and sporadic MPNST: The Mayo Clinic experience.

被引：0
|
作者：
Johnson, K. N.
Stucky, C. H.
Pockaj, B. A.
Gray, R. J.
Rose, P. S.
Wasif, N.
机构：
[1] Mayo Clin, Phoenix, AZ USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.10066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10066
引用
收藏
页数：1
相关论文
共 50 条
  • [41] HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)
    Lopez, Gonzalo
    Bill, Kate Lynn J.
    Bid, Hemant Kumar
    Braggio, Danielle
    Constantino, Dylan
    Prudner, Bethany
    Zewdu, Abeba
    Batte, Kara
    Lev, Dina
    Pollock, Raphael E.
    PLOS ONE, 2015, 10 (07):
  • [42] Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
    Kahn, Jenna
    Gillespie, Andy
    Tsokos, Maria
    Ondos, John
    Dombi, Eva
    Camphausen, Kevin
    Widemann, Brigitte C.
    Kaushal, Aradhana
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [43] Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NFI):: Diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene
    Friedrich, RE
    Kluwe, L
    Fünsterer, C
    Mautner, VF
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1699 - 1702
  • [44] Long-Term Outcomes of Radiation Therapy (RT) in the Management of Malignant Peripheral Nerve Sheath Tumors (MPNST) in Patients with Neurofibromatosis Type 1 (NF1)
    Sloan, L.
    Terezakis, S. A.
    Blakeley, J. O.
    Slobogean, B.
    Kleinberg, L. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E474 - E475
  • [45] Malignant peripheral nerve sheath tumors (MPNST) - Clinicopathological study and treatment outcome of twenty-four cases
    Kar M.
    Suryanarayana Deo S.V.
    Shukla N.K.
    Malik A.
    DattaGupta S.
    Mohanti B.K.
    Thulkar S.
    World Journal of Surgical Oncology, 4 (1)
  • [46] Pediatric Neurofibromatosis type 1-associated Malignant Peripheral Nerve Sheath Tumors: a national experience
    Silva, E. M.
    Nunes, S.
    Luz, I
    Mohanlal, U.
    Passos, J.
    NEURO-ONCOLOGY, 2022, 24
  • [47] Integrative Clinical and Biopathological Analyses in Malignant Peripheral Nerve Sheath Tumors (MPNST): Results of a French Expert Center
    Chaix, J.
    Pissaloux, D.
    Corradini, N.
    Verite-Goulard, C.
    Tirode, F.
    Karanian, M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S265 - S266
  • [48] Clinicopathological prognostic and predictive factors of malignant peripheral nerve sheath tumors (MPNST) survival and treatment efficacy.
    Sobczuk, Pawel
    Teterycz, Pawel
    Zdzienicki, Marcin
    Napierala, Marcin
    Morysinski, Tadeusz
    Switaj, Tomasz
    Rutkowski, Piotr
    Czarnecka, Anna Malgorzata
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Role Of 18F-FDG PET/CT In Management Of Malignant Peripheral Nerve Sheath Tumors (MPNST)
    Yadav, D.
    Shamim, S. A.
    Rastogi, S.
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S532 - S532
  • [50] Outcome of patients with refractory malignant peripheral nerve sheath tumors (MPNST) enrolled on phase 2 trials.
    Akshintala, Srivandana
    Mallory, Nicole C.
    Lu, Yao
    Ballman, Karla V.
    Kim, AeRang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345